Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after ...

Alembic Pharmaceuticals will miss the first wave of global generic semaglutide launches but is evaluating entry into the ...

Alembic Pharmaceuticals posted double-digit revenue growth in Q3, with margins steady, though a one-time labour code ...

With this approval, Alembic’s cumulative ANDA approvals from the USFDA now stand at 234, comprising 214 final approvals and ...

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 860 in its research report dated5, 2026.

The Food and Drug Administration has granted Alembic permission for Dabigatran Etexilate Capsules, 110 mg, which is the generic of Boehringer Ingelheim’s Pradaxa. Dabigatran Etexilate capsules 110 mg ...

Generic drugmaker Alembic Pharmaceuticals is recalling one lot of 20 mg telmisartan tablets after a bottle was found to contain the wrong dose. The India-based company received a market complaint that ...

Alembic has received The Food and Drug Administration’s clearance for two generics. The company obtained approvel for albendazole tablets, 200 mg, which is the generic of Impax's Albenza. Albendazole ...

International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

SAN FRANCISCO--(BUSINESS WIRE)--Alembic, the leading holistic marketing attribution platform for enterprises, today announced it received $14 million in series A funding. The round was led by WndrCo, ...